GALMED PHARMACEUTICALS LTD. Proceeds from Sale of Debt Securities, Available-for-sale
GALMED PHARMACEUTICALS LTD. (GLMD) reported Proceeds from Sale of Debt Securities, Available-for-sale of $2.54 million for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. proceeds from sale of debt securities, available-for-sale for the quarter ending 2025-12-31 was $825.00K, a 33.31% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. proceeds from sale of debt securities, available-for-sale for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. proceeds from sale of debt securities, available-for-sale for the quarter ending 2024-12-31 was $1.24M.
- GALMED PHARMACEUTICALS LTD. proceeds from sale of debt securities, available-for-sale for the quarter ending 2024-09-30 was $1.16M.
| Period end | Proceeds from Sale of Debt Securities, Available-for-sale 3 month | Proceeds from Sale of Debt Securities, Available-for-sale 6 month | Proceeds from Sale of Debt Securities, Available-for-sale 9 month | Proceeds from Sale of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.54M 6-K · filed 2026-09-02 | |||
| 2025-12-31 | $825.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $825.00K derived: sum of 2 quarters · filed 2026-03-31 | $1.61M 20-F · filed 2026-03-31 | |
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $786.00K 6-K · filed 2025-11-26 | ||
| 2025-06-30 | $786.00K 6-K · filed 2026-09-02 | |||
| 2024-12-31 | $1.24M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $2.40M derived: sum of 2 quarters · filed 2026-03-31 | $5.50M 20-F · filed 2026-03-31 | |
| 2024-09-30 | $1.16M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $4.27M 6-K · filed 2025-11-26 | ||
| 2024-06-30 | $3.11M 6-K · filed 2025-08-28 | |||
| 2023-12-31 | $8.63M 20-F · filed 2026-03-31 | |||
| 2023-06-30 | $7.52M 6-K · filed 2024-08-28 | |||
| 2022-12-31 | $21.44M 20-F · filed 2025-04-02 | |||
| 2021-12-31 | $21.24M 20-F · filed 2024-04-04 | |||
| 2020-12-31 | $47.20M 20-F · filed 2023-03-29 | |||
| 2019-12-31 | $101.10M 20-F · filed 2022-05-02 |